Hagar Mor Shaked, PhD. is an esteemed clinical genetic analyst with over 10 years of experience in molecular genetics, genomics, and bioinformatics in clinical and academic settings. I am head of bioinformatics at the genetic department of Hadassah University Medical Center and the product manager at Geneyx. My expertise lies in utilizing various next-generation sequencing (NGS) methodologies to diagnose rare diseases. I've analyzed thousands of clinical exome and genome sequencing tests and established a comprehensive genomic database, contributing significantly to the field. Additionally, I've published more than a dozen high-quality academic papers. Hagar holds an MSc in genetic counseling and a Ph.D. in human genetics, reflecting her extensive educational background and dedication to advancing genomic medicine.

Suzie Drury, PhD. Dr. Drury has over 20 years’ experience in biotech, NHS and academia across a range of clinical disciplines, with a focus on the implementation of new genomic technologies to clinical care, including personalised medicine, paediatric rare disease and non-invasive prenatal diagnosis.

Dr. Drury was Principal Investigator for the HAPPY (Healthy Aging Pharmacogenomics and Polypharmacy) trial, which looked at the implementation of pharmacogenomics into primary care and led an Innovate UK funded project on development of clinical decision support solutions for pharmacogenomics.

She has experience in clinical interpretation for rare disease, including for the UK 100,000 Genomes Project, product development, translational research and clinical implementation. Dr Drury has also been Head of Laboratory, establishing a rapid exome sequencing service and conducting research in the field of prenatal and non-invasive prenatal diagnosis.

Ali Tabish, MD PhD, is a clinical geneticist with a great passion for genomics and personalized medicine. My routine work involves the clinical evaluation of patient(s) and their families who have a history or suspicion of genetic disorders. Parents visit our clinic with their child having growth delays, unusual behaviour, physical abnormality (aka dysmorphic feature), etc, or an adult cancer patient or patient with heart complaints (e.g., cardiomyopathies).

I bridge clinical evaluation to genetic evaluation. I am also skilled in NGS data analysis and interpretation, bioinformatics, and clinical expert in genotype-phenotype correlations, variant curation and clinical reporting as per ACMG/AMP guidelines and genetic counseling.  Over the years, I have reported >18K genetic patient(s) presenting with diverse and unique clinical presentations. These patients were investigated predominantly with WES or gene panels but also with WGS, arrays, MLPA and Sanger sequencing.